MRC1 and cancer: Accumulating evidence suggests that the TME polarizes macrophages toward a protumor phenotype in multiple types of cancers.27 In the current study, the results of the analysis of macrophage subsets revealed robust expression of MRC1 (encoding CD206) and CD163 (Fig. S6a–c).